Clinical Trial Update: P13Kinase Inhibitor BKM120 in Combination With Panitumumab in Metastatic/Advanced RAS-Wild Type Colorectal Cancer. [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for a combination of a PI3K inhibitor BKM120 with panitumumab in metastatic/advanced RAS-wild type colorectal cancer (Phase 1/Phase 2, com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• BKM120 (Buparlisib)
• Panitumumab (panitumumab)

Snippet

Sponsor: Canadian Cancer Trials Group | Conditions: Metastatic Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED